Pegylated interferon alfa-2B induced lupus in a patient with chronic hepatitis B virus infection: case report

dc.contributor.authorYilmaz, Sema
dc.contributor.authorCimen, Kadriye Akar
dc.date.accessioned2020-03-26T17:39:35Z
dc.date.available2020-03-26T17:39:35Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractDrug-induced lupus is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation of the offending drug. Newer biological agents such as interferons (IFN) and anti-tumor necrosis factor-alpha therapies have been involved in the induction of lupus-like syndromes. Prompt recognition and discontinuation of the suspected drug are associated with excellent outcomes in most cases. In this article, we present the case who developed lupus during therapy with pegylated-IFN alpha-2b for chronic hepatitis B virus infection after 8 months.en_US
dc.identifier.doi10.1007/s10067-009-1239-3en_US
dc.identifier.endpage1243en_US
dc.identifier.issn0770-3198en_US
dc.identifier.issue10en_US
dc.identifier.pmid19653058en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1241en_US
dc.identifier.urihttps://dx.doi.org/10.1007/s10067-009-1239-3
dc.identifier.urihttps://hdl.handle.net/20.500.12395/23750
dc.identifier.volume28en_US
dc.identifier.wosWOS:000269530300021en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSPRINGERen_US
dc.relation.ispartofCLINICAL RHEUMATOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectHepatitis Ben_US
dc.subjectInterferonen_US
dc.subjectLupusen_US
dc.titlePegylated interferon alfa-2B induced lupus in a patient with chronic hepatitis B virus infection: case reporten_US
dc.typeArticleen_US

Dosyalar